Posts With Tag NASDAQ VRPX

Explore Virpax Pharmaceuticals, Inc.'s significant 8-K filing from January 15, 2025, revealing corporate changes, stock info, and contact details for investors.

Explore Virpax Pharmaceuticals, Inc.'s recent 8-K filing, revealing crucial corporate developments and financial insights effective December 30, 2024.